MRCP2-1849

A 28-year-old woman with a history of intravenous drug use presents to the hepatology clinic at 16 weeks gestation. She has chronic hepatitis C and was unsuccessfully treated with pegylated interferon-alpha, ribavirin, and a protease inhibitor a year ago. What measures can be taken to minimize the risk of vertical transmission?